Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy

Full text for this resource is not available from the Research Repository.

Dass, Crispin R, Galloway, Stuart J, Clark, Jonathan C. M, Khachigian, Levon M and Choong, Peter F. M (2008) Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy. Cancer Biology and Therapy, 7 (8). pp. 1297-1301. ISSN 1538-4047

Abstract

c-jun has been found to be upregulated in a variety of cancers. Recently, this oncogene has also been implicated in liposarcoma (LS) progression. c-jun knockdown mediated by a deoxyribozyme induced apoptosis in LS cells via evoking caspase-10, but not the Fas/FasL pathway. A novel orthotopic model for LS was established in the hindlimb of mice using human cells to extend the evaluation of effects of c-jun knockdown in vivo. Tumor take in vivo was 100%, with growths resembling high grade aggressive LS. The c-jun deoxyribozyme inhibited the growth of LS in this model. Clinically, downregulation of c-jun may proffer an improved treatment outcome for liposarcoma. The new model for LS described here will enable better testing of agents with therapeutic potential against LS.

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/3598
DOI 10.4161/cbt.7.8.6301
Official URL http://www.landesbioscience.com/journals/cbt/artic...
Subjects Historical > RFCD Classification > 320000 Medical and Health Sciences
Historical > FOR Classification > 1117 Public Health and Health Services
Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
Keywords ResPubID18868. c-jun, cancer, apoptosis, deoxyribozyme, liposarcoma, orthotopic, gene therapy
Citations in Scopus 26 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login